1 / 7

Sarcoidosis Therapeutics Market size and forecast, 2017-2027

Future Market Insights has announced the addition of the “ Sarcoidosis Therapeutics Market: Global Industry Analysis and Opportunity Assessment 2017-2027”report to their offering.

hussainshah
Download Presentation

Sarcoidosis Therapeutics Market size and forecast, 2017-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Sarcoidosis Therapeutics Market Global Industry Analysis, size, share and Forecast 2017-2027 April 2017 Report Id : REP-GB-3340 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices ©2015 Future Market Insights, All Rights Reserved

  2. About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights,aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology,Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solutionfor our client. Research Capabilities Sector Coverage             Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Social Media Research ©2015 Future Market Insights, All Rights Reserved 2

  3. Research Methodology (1/2) Systematic Research Approach 1 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Research & Intelligence Data Collection Data Filter & Analysis Actionable Insights Business Solution Market profiling 2 PMR formulates a detailed discussion guide to conduct expert and industry interviews     Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Formulating discussion guide 3 A PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts Primary Research       Key industry experts Channel study Developments Market dynamics Products Conclusions Developing list of respondents B 4 PMR conducts interviews with industry experts, industry players, distributors and retailers SOLUTION Desk Research Data collection      Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments C Company Analysis Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data 5 Data validation 6 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry Data analysis Primary Research# Secondary Research # Paid Publications#           Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater 7 PMR delivers industry insights and information in the required format (PDF) Insights   # includes sources of databases ©2015 Future Market Insights, All Rights Reserved 3

  4. Sarcoidosis Therapeutics Market Sarcoidosis Therapeutics Market Global Industry Analysis, size, share and Forecast 2017-2027 Sarcoidosis also known as Besnier-Boeck-Schaumann disease is an inflammatory disease characterized by formation of garnulomas. The autoagressive systemic disease affects the organs throughout the body where the nodules contains collection of inflammatory cells. In majority of the cases sarcoidosis is cured within a year or two and only 30% of the sarcoidosis develop chronic disease. The market for sarcoidosis therapeutics is expected to boom due to the number of research undertaking and funding to control the rising prevalence of this disease. NIH granted USD 8.3 million to the University of Pittsburgh to explore the relationship between lung bacteria, the gene activation process and sarcoidosis disease progression. For the sarcoidosis study the Genomics and Informatics Center would collect patient clinical data from seven clinical center and use advanced microbiome and genome profiling techniques to identify biomarkers. These biomarkers would help identify the current state of lung disease and further predict its progression. Such integration of microbiome, genome and clinical information for sarcoidosis disease would dramatically change its management. Sarcoidosis therapeutics market has been segmented on the basis of diagnosis, treatment and region. Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3340 The number of clinical trials undertaken for sarcoidosis has increased past some years. The disease is highly undiscovered and hence offers a potential for industry players to mark their market presence. ©2015 Future Market Insights, All Rights Reserved 4

  5. Sarcoidosis Therapeutics Market Some companies such as Auven Therapeutics have obtained rights from research universities to further carry out clinical trials on a new molecule. Auven Therapeutics obtained rights to futher develop KIACTA from the Icahn School of Medicine. The research is now carried as a collaborative effort between Auven Therapeutics and BELLUS Health. The companies are evaluating the potential use of KIACTA for the treatment of patients suffering from pulmonary sarcoidosis. They have developed a Phase2/3 protocol to evaluate the efficacy and safety of KIACTA in sarcoidosis. Geographically, sarcoidosis therapeutics market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East and Africa. North America region is projected to dominate the sarcoidosis therapeutics marketover the forecast period. The amount of research undertaken by various companies, industry academia partnership and funding to encourage more research are some of the factors contributing to North Americas lion share. Europe is the second largest region in terms of revenue share as it also has number of clinical trials ongoing. Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3340 Asia Pacific is expected to be the fastest growing region for the sarcoidosistherapeutics market. The region is expected to boom owing to the prevalence rate and grants received from various international associations. A professor from National Jewish Health, received USD 40,000 per for two years from the Foundation for Sarcoidosis Research (FSR) grant /American Thoracic Society. The Foundation for Saroidosis Research (FSR) is a non-profit organization dedicated to find a cure or improve care for ©2015 Future Market Insights, All Rights Reserved 5

  6. Sarcoidosis Therapeutics Market sarcoidosis. The foundation has awarded USD 1 million for research and additional USD 1.2 million for funding to investigators. Key Players Some of the key players in sarcoidosis therapeutics market include Bellus Helath, FirstString Research Inc., Relief Therapeutics, Araim Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, PharmaIN Corporation, Adaptimmune Therapeutics Plc, EpiZyme, Inc. and Advenchen Laboratories, LLC. Browse Full Report@ http://www.futuremarketinsights.com/reports/sarcoidosis-therapeutics-market ©2015 Future Market Insights, All Rights Reserved 6

  7. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Harish Tiwari (General Manager & Global Head Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Future Market Insights Global & Consulting Private Limited (FMI) Thank You ©2015 Future Market Insights, All Rights Reserved 7

More Related